NASDAQ: REGN · Biotechnology
Over the past week, Regeneron Pharmaceuticals (REGN) drew about 34 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 25% bullish but is far apart: News runs 50% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 17 of 27 analysts rating REGN a buy.
There is little buzz around REGN this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 63% buy share sits next to a crowd that ranges from Reddit at 0% to News at 50%. No other tracker puts the two side by side.
Across 27 analysts the consensus is a Strong Buy: 17 buy calls against 1 sell, with an average 12-month price target of $856.23.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 38 points above the crowd average of 25%, the professionals are more constructive than retail. The split is inside the crowd: News reads 50% bullish while Reddit sits at 0%, a 50-point spread that single-source trackers miss.
Over the 30-day window, Regeneron Pharmaceuticals (REGN) buzz held subdued around 25.0 while the price drifted down 4.5% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 750K shares. Updated Oct 10, 2026. Over the last 7 trading days, REGN gained 1.6%. Buzz activity in the recent week averaged 37.5 and was variable, swinging between 25.0 and 49.8. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 16 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for REGN and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live REGN sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (17 / 9 / 1) |
| Crowd bullish (7d) | 25% |
| Avg price target | $856.23 |
| Most bullish source | News, 50% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 50 pts |
| Mentions (7d) | 34 |
| Market cap | $76.14B |
| P/E · Forward P/E | 18.3 · 14.5 |
| EPS · Beta | $40.44 · 0.2 |
| Revenue (TTM) | $15.53B · 28% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Regeneron Pharmaceuticals (REGN) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 25% bullish across 3 active sources. Those sources contribute 34 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Regeneron Pharmaceuticals (REGN) is fairly quiet with 1 mentions over the last 7 days; the 30-day context spans 4 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Regeneron Pharmaceuticals (REGN), averaging 25% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 50% bullish and Reddit at 0%, a 50-point spread. On the professional side, 17 of 27 analysts rate REGN a buy.
Of the 27 analysts covering Regeneron Pharmaceuticals (REGN), 17 rate it a buy, 9 a hold and 1 a sell, for a strong buy consensus. The average price target is $856.23. That puts the street ahead of the crowd, which averages 25% bullish.
Regeneron Pharmaceuticals (REGN)'s cross-source average is bearish at 25% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. X reads 24% bullish, News reads 50% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Regeneron Pharmaceuticals (REGN) at 25% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is falling across X and News. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 21 mentions (62% of total volume). News contributes 12 mentions and Reddit contributes 1 mention. The cross-source average is bearish at 25% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. REGN's sell signal at 93/100 conviction reflects a bearish cross-source average at 25% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The REGN sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key